This poster describes the use of CRISPR-ready iPSCs ... Designing and performing assays that accurately measure small molecule binding kinetics is an important part of the drug discovery process. It ...

Initiated Phase 1b dose expansion of NX-5948 in chronic lymphocytic leukemia patient population with Fast Track Designation from the FDAInitiated ...

Two posters presented at the CHEST 2024 annual meeting show that although inhaled treprostinil reduces hospitalizations in ...

Data Supports Deramiocel’s Sustained Efficacy and Safety in Treating DMD--Improvements Seen in Multiple Cardiac and Skeletal Endpoints ...

In the fast-paced world of drug discovery, staying updated with the latest advancements is crucial. This eBook offers a unique opportunity to explore a curated selection of posters that were ...

Mumbai: Sun Pharmaceutical Industries Limited has announced that it will present abstracts across its dermatology portfolio ...

Fake signs apparently permitting drug-taking have appeared in parts of Leeds city centre. Posters indicating a "crack and heroin zone" were spotted on Kirkgate and Briggate on Wednesday.

NDAQ:SRRK) Scholar Rock Reports Apitegromab Meets Primary Endpoint in Phase 3 SAPPHIRE Study in Patients with Spinal Muscular ...

MNOV READ THE FULL MNOV RESEARCH REPORT On September 30, 2024, MediciNova, Inc. (NASDAQ:MNOV) announced that MN-166 (ibudilast) will be evaluated in an Expanded Access Protocol (EAP) trial to evaluate ...

Using the Muscarinic M1 G-protein Coupled Receptor as a model system, we achieved accurate and reproducible determinations of binding affinity (Kd) and IC50 results for known ligands on the 384-well ...